NYSE$HIMS

Hims & Hers Health Inc · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Briefing

Hims & Hers reported Q3 2025 revenue of $599.0M with net income of $15.8M and diluted EPS of $0.06.

Revenue increased to $599.0 million with net income of $15.8 million versus a loss a year ago. The telehealth platform continued scaling subscribers across weight management, mental health, and other personalized care categories.

  • Q3 revenue $599.0M.
  • Net income $15.8M; diluted EPS $0.06.
  • Subscriber growth and mix shift support margin expansion.
  • Marketing and fulfillment investments remain elevated.

Headline financials

Total Revenue

$599M

Previous: $402M+49.2%
EPS (adj)

$0.06

Previous: $0.32-81.3%
Subscribers

2.5M

Previous: 2.0M+20.7%
Monthly Online Rev per Avg Sub

$80.00

Previous: $67.00+19.4%
Adjusted EBITDA

$78.4M

No prior period
Gross Margin

74.0%

Previous: 79.0%-6.3%
Adjusted EBITDA Margin

13.0%

Previous: 13.0%+0.0%
Net Income

$15.8M

Previous: $75.6M-79.1%
Operating Income

$11.8M

Previous: $22.4M-47.2%
Gross Profit

$442M

Previous: $318M+39.1%

Revenue & EPS history

Hims & Hers · Revenue · Quarterly

$599M

Q3 2025+49.2%vs Q3 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Hims & Hers · $227M total across 2 segments · Q3 2023

  • Online Revenue
    $220M+57.1%
  • Wholesale Revenue
    $7.03M+39.1%

Forward guidance

The filing discusses Hims & Hers Health's outlook, capital deployment, and key risks without relying solely on numeric EPS guidance.

Tailwinds

  • Hims & Hers Health cites execution on strategic priorities in the filing.
  • Balance sheet and liquidity support continued operations.

Headwinds

  • Macro, competitive, and cost pressures may affect margins.
  • Segment mix and one-time items can affect comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+2.5%

Avg return

Earnings day

+3.8%

Avg return

5 days after

+11.7%

Avg return

30 days after

50%

13 / 26 earnings

Positive

+41.1%

Q4 2023

Best reaction

-22.3%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.0%-11.4%-1.8%
Q4 2025-2.8%-6.4%+34.5%
Q3 2025-3.6%-7.6%-9.8%
Q1 2025+18.5%+24.1%+26.0%
Q4 2024-22.3%-12.1%-37.8%
Q3 2024+1.4%+15.0%+66.6%
Q2 2024-4.0%-9.2%-16.9%
Q1 2024+9.7%+9.1%+93.2%
Q4 2023+41.1%+37.8%+65.3%
Q3 2023+7.6%+5.1%+37.3%
Q2 2023-8.7%-11.7%-15.2%
Q1 2023-11.5%-10.2%-23.9%
Q4 2022+15.4%+6.0%+2.7%
Q3 2022+30.1%+37.2%+64.7%
Q2 2022-3.4%+9.2%-0.6%
Q1 2022-13.0%-13.5%+5.3%
Q4 2021+8.0%+20.5%+19.8%
Q3 2021-7.0%-1.3%-26.3%
Q2 2021+7.0%-4.7%+11.1%
Q1 2021+13.7%+44.9%+33.1%
Q2 2020-8.4%-7.2%-21.9%
Q4 2020-7.5%-15.4%-21.3%
Q3 2020+0.1%+0.0%+17.5%
Q1 2020-0.7%-0.5%+0.1%
Q4 2019+1.4%+2.1%+2.2%
Q3 2019+0.0%+0.3%-0.6%
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro